Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 05, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

SAN DIEGO, July 05, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it has entered into definitive agreements with healthcare-focused institutional investors for...
July 02, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual Meeting

A sponsored session will feature Dr. Lucia Gallego Villarejo from Ruhr University Bochum, Dr. Jeanne Loring from Scripps Research Institute, and Dr. Alicia Bertolotti from Bionano presenting on the...
June 20, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research

Bionano announces software marketing agreement with Revvity for newborn sequencing research workflow.
May 30, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces Robust Presence at Upcoming Cytogenetics Conferences ESHG and ACC with 39 Scientific Presentations and Posters Highlighting the Utility of the Optical Genome Mapping Workflow

Bionano announces a record 39 scientific presentations and posters highlighting optical genome mapping at two upcoming global cytogenetics conferences.
May 28, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet

Bionano Announces Private Placement of Senior Secured Notes in Debt Restructuring that Improves Balance Sheet
May 21, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces Three Publications Demonstrating OGM’s Utility for Cell and Gene Therapy

Optical genome mapping was used in three publications to successfully assess genome integrity in stem cells, CAR-T cells, and iPSCs.
May 09, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis

Bionano announces significant advancements to its suite of computational tools for comprehensive cancer analysis.
May 08, 2024 16:01 ET | Source: Bionano Genomics

Bionano Reports First Quarter 2024 Results and Highlights Recent Business Progress

Q1 2024 revenue was $8.8 million, which represents an 18% increase over Q1 2023Total installed base of 347 optical genome mapping (OGM) systems as of Q1 2024, which represents a 34% increase over Q1...
May 01, 2024 08:00 ET | Source: Bionano Genomics

Bionano to Report First Quarter 2024 Financial Results and Host a Conference Call and Webcast on May 8, 2024

SAN DIEGO, May 01, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, May 8, 2024, at 4:30 p.m. Eastern...
April 30, 2024 16:05 ET | Source: Bionano Genomics

Bionano to Present at the RBC Capital Markets 2024 Global Healthcare Conference

SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the RBC...